Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Wei Zhang, Lili Xu, Shen Gao, Nan Ding, Ping Shu, Zhuo Wang & Yuping Li. (2020) Technical Evaluation of Soft Mist Inhaler Use in Patients with Chronic Obstructive Pulmonary Disease: A Cross-Sectional Study. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 1471-1479.
Read now
Read now
Shiyuan Zhang, Denise King, Virginia M Rosen & Afisi S Ismaila. (2020) Impact of Single Combination Inhaler versus Multiple Inhalers to Deliver the Same Medications for Patients with Asthma or COPD: A Systematic Literature Review. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 417-438.
Read now
Read now
Gary T. Ferguson & Richard N. Dalby. (2018) Clinical implications of the tiotropium/olodaterol inhaler for patients with chronic obstructive pulmonary disease. Postgraduate Medicine 130:6, pages 515-522.
Read now
Read now
Marc Miravitlles, Jéssica Montero-Caballero, Frank Richard, Salud Santos, Juan Luis Garcia-Rivero, Francisco Ortega & Xavier Ribera. (2016) A cross-sectional study to assess inhalation device handling and patient satisfaction in COPD. International Journal of Chronic Obstructive Pulmonary Disease 11, pages 407-415.
Read now
Read now
Basil G Bereza, Anders Troelsgaard Nielsen, Sverrir Valgardsson, Michiel EH Hemels & Thomas R Einarson. (2015) Patient preferences in severe COPD and asthma: a comprehensive literature review. International Journal of Chronic Obstructive Pulmonary Disease 10, pages 739-744.
Read now
Read now
Articles from other publishers (14)
M. Matuszak, M. Ochowiak, S. Włodarczak, A. Krupińska & M. Doligalski. (2022) State-of-the-art review of the application and development of various methods of aerosol therapy. International Journal of Pharmaceutics 614, pages 121432.
Crossref
Crossref
Omar S. Usmani, Anthony J. Hickey, Deniz Guranlioglu, Kacey Rawson, Neda Stjepanovic, Shahid Siddiqui & Rajiv Dhand. (2021) The Impact of Inhaler Device Regimen in Patients with Asthma or COPD. The Journal of Allergy and Clinical Immunology: In Practice 9:8, pages 3033-3040.e1.
Crossref
Crossref
Maryam Navaie, Carole Dembek, Soojin Cho-Reyes, Karen Yeh & Bartolome R. Celli. (2020) Inhaler device feature preferences among patients with obstructive lung diseases. Medicine 99:25, pages e20718.
Crossref
Crossref
Santhalingam Balamurugan, Komalkirti Apte, Bhanu Pratap Singh, Ashish Kumar Deb, Chandrahas Deshmukh, Kinjal Modi, Ajay Godse, Raja Dhar, Keya Rani Lahiri, Virendra Singh, Hiren Pandya, Sujeet Rajan, Abhijit Vaidya, Vaibhav Gaur & Jaideep Gogtay. (2020) Device-handling study of a novel breath-actuated inhaler, Synchrobreathe®, versus a pMDI. Respiratory Medicine 161, pages 105707.
Crossref
Crossref
Takashi Iwanaga, Yuji Tohda, Shuhei Nakamura & Yasunori Suga. (2019) The Respimat® Soft Mist Inhaler: Implications of Drug Delivery Characteristics for Patients. Clinical Drug Investigation 39:11, pages 1021-1030.
Crossref
Crossref
Dominik Kappeler, Knut Sommerer, Claudius Kietzig, Bärbel Huber, Jo Woodward, Mark Lomax & Prashant Dalvi. (2018) Pulmonary deposition of fluticasone propionate/formoterol in healthy volunteers, asthmatics and COPD patients with a novel breath-triggered inhaler. Respiratory Medicine 138, pages 107-114.
Crossref
Crossref
Marc Miravitlles, Juan José Soler-Cataluña, Bernardino Alcázar, José Luis Viejo & Francisco García-Río. (2018) Factors affecting the selection of an inhaler device for COPD and the ideal device for different patient profiles. Results of EPOCA Delphi consensus. Pulmonary Pharmacology & Therapeutics 48, pages 97-103.
Crossref
Crossref
Kimberly H. Davis, Jun Su, Juan Marcos González, Jeremiah J. Trudeau, Lauren M. Nelson, Brett Hauber & Kelly A. Hollis. (2017) Quantifying the importance of inhaler attributes corresponding to items in the patient satisfaction and preference questionnaire in patients using Combivent Respimat. Health and Quality of Life Outcomes 15:1.
Crossref
Crossref
Natalia Hawken, Saku Torvinen, Mohamed-Elmoctar Neine, Ikbel Amri, Mondher Toumi, Samuel Aballéa, Adam Plich & Nicolas Roche. (2017) Patient preferences for dry powder inhaler attributes in asthma and chronic obstructive pulmonary disease in France: a discrete choice experiment. BMC Pulmonary Medicine 17:1.
Crossref
Crossref
David BellLucielle MansfieldMark Lomax. (2017) A Randomized, Crossover Trial Evaluating Patient Handling, Preference, and Ease of Use of the Fluticasone Propionate/Formoterol Breath-Triggered Inhaler. Journal of Aerosol Medicine and Pulmonary Drug Delivery 30:6, pages 425-434.
Crossref
Crossref
Roberto W. Dal Negro & Massimiliano Povero. (2016) Acceptability and preference of three inhalation devices assessed by the Handling Questionnaire in asthma and COPD patients. Multidisciplinary Respiratory Medicine 11:1.
Crossref
Crossref
TR MacGregor, R ZuWallack, V Rubano, MA Castles, H Dewberry, M Ghafouri & CC Wood. (2016) Efficiency of Ipratropium Bromide and Albuterol Deposition in the Lung Delivered via a Soft Mist Inhaler or Chlorofluorocarbon Metered‐Dose Inhaler. Clinical and Translational Science 9:2, pages 105-113.
Crossref
Crossref
Sergi Pascual, Jan Feimer, Anthony De Soyza, Jaume Sauleda Roig, John Haughney, Laura Padullés, Beatriz Seoane, Ludmyla Rekeda, Anna Ribera & Henry Chrystyn. (2015) Preference, satisfaction and critical errors with Genuair and Breezhaler inhalers in patients with COPD: a randomised, cross-over, multicentre study. npj Primary Care Respiratory Medicine 25:1.
Crossref
Crossref
John Gar Yan Chan, Jennifer Wong, Qi Tony Zhou, Sharon Shui Yee Leung & Hak-Kim Chan. (2014) Advances in Device and Formulation Technologies for Pulmonary Drug Delivery. AAPS PharmSciTech 15:4, pages 882-897.
Crossref
Crossref